Markets:

Overview

News

Currencies

International

Treasuries

Solventum Corporation Common Stock (NY:SOLV)

82.44 -0.54 (-0.65%)

Delayed Quote Updated: 11:57 AM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

2 cash-burning stocks for long-term investors and 1 we turn down

October 23, 2026

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sh...

Via StockStory

Topics Credit Cards

Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.

October 06, 2026

From Wall Street Investor

Via GlobeNewswire

3 Overrated Stocks We Approach with Caution

October 02, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...

Via StockStory

Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)

October 01, 2026

Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NY...

Via StockStory

Topics Artificial Intelligence Economy

Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds ↗

September 23, 2026

Via Chartmill

2 Profitable Stocks for Long-Term Investors and 1 We Question

September 29, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Due Diligence Check: Do These "Blue Chips" Still Earn the Title? ↗

September 23, 2026

"Blue chip" gets applied to a company once and tends to stick, regardless of what the balance sheet does afterward. The label describes reputation, not cur

Via Talk Markets

Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses

September 15, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a...

Via StockStory

Topics Artificial Intelligence Economy

3 S&P 500 Stocks with Open Questions

September 09, 2026

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Via StockStory

Topics Stocks

2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm

August 31, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

Topics Energy

3 Value Stocks with Open Questions

August 28, 2026

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

Via StockStory

3 Reasons to Avoid SOLV and 1 Stock to Buy Instead

August 28, 2026

Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due t...

Via StockStory

Topics Stocks

1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges

August 20, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Via StockStory

Solventum (SOLV) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.

Via The Motley Fool

Topics Earnings World Trade

The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

August 12, 2026

News Provided by USA News Group on behalf of Conexeu Sciences Inc.

From USA News Group

Via GlobeNewswire

Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks

August 11, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how surgical equipment & c...

Via StockStory

Topics Artificial Intelligence Economy

Solventum Q2 Earnings Call Highlights ↗

August 09, 2026

Solventum (NYSE:SOLV) reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff...

Via MarketBeat

Topics ETFs Earnings World Trade

SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook

August 07, 2026

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2....

Via StockStory

Solventum Nears Inflection Point As It Begins to Unlock Value ↗

August 07, 2026

Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.

Via MarketBeat

Topics Initial Public Offering

Explore the top gainers and losers within the S&P500 index in today's session. ↗

August 06, 2026

Via Chartmill

Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026

August 05, 2026

Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to ...

Via StockStory

Stay updated with the S&P500 stocks that are on the move in today's after-hours session. ↗

August 05, 2026

Via Chartmill

What To Expect From Solventum’s (SOLV) Q2 Earnings

August 03, 2026

Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results this Wednesday after market hours. Here’s what you need to know. Solventum beat...

Via StockStory

3 Hyped Up Stocks That Fall Short

July 31, 2026

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements...

Via StockStory

Exploring the top movers within the S&P500 index during today's session. ↗

July 28, 2026

Via Chartmill

Tuesday's session: top gainers and losers in the S&P500 index ↗

July 28, 2026

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

July 28, 2026

Via Chartmill

3 Reasons SOLV is Risky and 1 Stock to Buy Instead

July 24, 2026

Since January 2026, Solventum has been in a holding pattern, posting a small loss of 2.2% while floating around $77.29. The stock also fell short of the S&P ...

Via StockStory

Topics Stocks

2 S&P 500 Stocks to Own for Decades and 1 We Question

July 07, 2026

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Via StockStory

Topics Stocks

3 Mid-Cap Stocks We Steer Clear Of

June 29, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Penticton Herald

Penticton Herald

Solventum Corporation Common Stock (NY:SOLV)

All News about Solventum Corporation Common Stock

Contact us

Sections

Services

Search